PMC:7095437 / 19080-19818 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"337","span":{"begin":21,"end":29},"obj":"Species"},{"id":"338","span":{"begin":293,"end":301},"obj":"Species"},{"id":"339","span":{"begin":347,"end":355},"obj":"Species"},{"id":"340","span":{"begin":390,"end":397},"obj":"Species"},{"id":"341","span":{"begin":471,"end":479},"obj":"Species"},{"id":"342","span":{"begin":526,"end":534},"obj":"Species"},{"id":"343","span":{"begin":568,"end":576},"obj":"Species"},{"id":"344","span":{"begin":615,"end":623},"obj":"Species"},{"id":"345","span":{"begin":35,"end":43},"obj":"Disease"}],"attributes":[{"id":"A337","pred":"tao:has_database_id","subj":"337","obj":"Tax:9606"},{"id":"A338","pred":"tao:has_database_id","subj":"338","obj":"Tax:9606"},{"id":"A339","pred":"tao:has_database_id","subj":"339","obj":"Tax:9606"},{"id":"A340","pred":"tao:has_database_id","subj":"340","obj":"Tax:9606"},{"id":"A341","pred":"tao:has_database_id","subj":"341","obj":"Tax:9606"},{"id":"A342","pred":"tao:has_database_id","subj":"342","obj":"Tax:9606"},{"id":"A343","pred":"tao:has_database_id","subj":"343","obj":"Tax:9606"},{"id":"A344","pred":"tao:has_database_id","subj":"344","obj":"Tax:9606"},{"id":"A345","pred":"tao:has_database_id","subj":"345","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The CT scores of all patients with COVID-19 are shown in Table 2 and the CT scores of each lobe in the two groups are shown in Fig. 6. The CT scores of the progressive-stage group were significantly greater than those of the early-stage group (p = 0.004). In the early-stage group, 27 (79.4%) patients had CT scores in the range of 0–5, 6 (17.6%) patients had CT scores of 6–10, and only 1 patient had a CT score of 11 or more. In the progressive-stage group, 10 (35.7%) patients had CT scores in the range of 0–5, 12 (42.9%) patients had CT scores of 6–10, 3 (10.7%) patients had CT scores of 11–15, and 3 (10.7%) patients had CT scores of 15 or more.\nFig. 6 The CT score of each lobe in the early-stage group and progressive-stage group"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T65","span":{"begin":91,"end":95},"obj":"Body_part"},{"id":"T66","span":{"begin":681,"end":685},"obj":"Body_part"}],"attributes":[{"id":"A65","pred":"uberon_id","subj":"T65","obj":"http://purl.obolibrary.org/obo/UBERON_3010752"},{"id":"A66","pred":"uberon_id","subj":"T66","obj":"http://purl.obolibrary.org/obo/UBERON_3010752"}],"text":"The CT scores of all patients with COVID-19 are shown in Table 2 and the CT scores of each lobe in the two groups are shown in Fig. 6. The CT scores of the progressive-stage group were significantly greater than those of the early-stage group (p = 0.004). In the early-stage group, 27 (79.4%) patients had CT scores in the range of 0–5, 6 (17.6%) patients had CT scores of 6–10, and only 1 patient had a CT score of 11 or more. In the progressive-stage group, 10 (35.7%) patients had CT scores in the range of 0–5, 12 (42.9%) patients had CT scores of 6–10, 3 (10.7%) patients had CT scores of 11–15, and 3 (10.7%) patients had CT scores of 15 or more.\nFig. 6 The CT score of each lobe in the early-stage group and progressive-stage group"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T78","span":{"begin":35,"end":43},"obj":"Disease"}],"attributes":[{"id":"A78","pred":"mondo_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"The CT scores of all patients with COVID-19 are shown in Table 2 and the CT scores of each lobe in the two groups are shown in Fig. 6. The CT scores of the progressive-stage group were significantly greater than those of the early-stage group (p = 0.004). In the early-stage group, 27 (79.4%) patients had CT scores in the range of 0–5, 6 (17.6%) patients had CT scores of 6–10, and only 1 patient had a CT score of 11 or more. In the progressive-stage group, 10 (35.7%) patients had CT scores in the range of 0–5, 12 (42.9%) patients had CT scores of 6–10, 3 (10.7%) patients had CT scores of 11–15, and 3 (10.7%) patients had CT scores of 15 or more.\nFig. 6 The CT score of each lobe in the early-stage group and progressive-stage group"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T156","span":{"begin":282,"end":284},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T157","span":{"begin":402,"end":403},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T158","span":{"begin":416,"end":418},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T159","span":{"begin":594,"end":596},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"The CT scores of all patients with COVID-19 are shown in Table 2 and the CT scores of each lobe in the two groups are shown in Fig. 6. The CT scores of the progressive-stage group were significantly greater than those of the early-stage group (p = 0.004). In the early-stage group, 27 (79.4%) patients had CT scores in the range of 0–5, 6 (17.6%) patients had CT scores of 6–10, and only 1 patient had a CT score of 11 or more. In the progressive-stage group, 10 (35.7%) patients had CT scores in the range of 0–5, 12 (42.9%) patients had CT scores of 6–10, 3 (10.7%) patients had CT scores of 11–15, and 3 (10.7%) patients had CT scores of 15 or more.\nFig. 6 The CT score of each lobe in the early-stage group and progressive-stage group"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T34","span":{"begin":174,"end":179},"obj":"Chemical"},{"id":"T35","span":{"begin":237,"end":242},"obj":"Chemical"},{"id":"T36","span":{"begin":275,"end":280},"obj":"Chemical"},{"id":"T37","span":{"begin":453,"end":458},"obj":"Chemical"},{"id":"T38","span":{"begin":705,"end":710},"obj":"Chemical"},{"id":"T39","span":{"begin":733,"end":738},"obj":"Chemical"}],"attributes":[{"id":"A34","pred":"chebi_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A35","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A36","pred":"chebi_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A37","pred":"chebi_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A38","pred":"chebi_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A39","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"}],"text":"The CT scores of all patients with COVID-19 are shown in Table 2 and the CT scores of each lobe in the two groups are shown in Fig. 6. The CT scores of the progressive-stage group were significantly greater than those of the early-stage group (p = 0.004). In the early-stage group, 27 (79.4%) patients had CT scores in the range of 0–5, 6 (17.6%) patients had CT scores of 6–10, and only 1 patient had a CT score of 11 or more. In the progressive-stage group, 10 (35.7%) patients had CT scores in the range of 0–5, 12 (42.9%) patients had CT scores of 6–10, 3 (10.7%) patients had CT scores of 11–15, and 3 (10.7%) patients had CT scores of 15 or more.\nFig. 6 The CT score of each lobe in the early-stage group and progressive-stage group"}

{"project":"LitCovid-sentences","denotations":[{"id":"T161","span":{"begin":0,"end":134},"obj":"Sentence"},{"id":"T162","span":{"begin":135,"end":255},"obj":"Sentence"},{"id":"T163","span":{"begin":256,"end":427},"obj":"Sentence"},{"id":"T164","span":{"begin":428,"end":652},"obj":"Sentence"},{"id":"T165","span":{"begin":653,"end":738},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The CT scores of all patients with COVID-19 are shown in Table 2 and the CT scores of each lobe in the two groups are shown in Fig. 6. The CT scores of the progressive-stage group were significantly greater than those of the early-stage group (p = 0.004). In the early-stage group, 27 (79.4%) patients had CT scores in the range of 0–5, 6 (17.6%) patients had CT scores of 6–10, and only 1 patient had a CT score of 11 or more. In the progressive-stage group, 10 (35.7%) patients had CT scores in the range of 0–5, 12 (42.9%) patients had CT scores of 6–10, 3 (10.7%) patients had CT scores of 11–15, and 3 (10.7%) patients had CT scores of 15 or more.\nFig. 6 The CT score of each lobe in the early-stage group and progressive-stage group"}